JP2021528450A5 - - Google Patents
Info
- Publication number
- JP2021528450A5 JP2021528450A5 JP2020571767A JP2020571767A JP2021528450A5 JP 2021528450 A5 JP2021528450 A5 JP 2021528450A5 JP 2020571767 A JP2020571767 A JP 2020571767A JP 2020571767 A JP2020571767 A JP 2020571767A JP 2021528450 A5 JP2021528450 A5 JP 2021528450A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- freeze
- pharmaceutical composition
- composition according
- dispersion
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18180177 | 2018-06-27 | ||
| EP18180177.0 | 2018-06-27 | ||
| PCT/EP2019/066875 WO2020002353A1 (en) | 2018-06-27 | 2019-06-25 | Pharmaceutical compositions in lyophilized form |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021528450A JP2021528450A (ja) | 2021-10-21 |
| JPWO2020002353A5 JPWO2020002353A5 (https=) | 2022-06-28 |
| JP2021528450A5 true JP2021528450A5 (https=) | 2022-06-28 |
| JP7401471B2 JP7401471B2 (ja) | 2023-12-19 |
Family
ID=62814888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571767A Active JP7401471B2 (ja) | 2018-06-27 | 2019-06-25 | 凍結乾燥形態の医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210244664A1 (https=) |
| EP (1) | EP3813788A1 (https=) |
| JP (1) | JP7401471B2 (https=) |
| CN (1) | CN113038930A (https=) |
| AU (1) | AU2019295027B2 (https=) |
| BR (1) | BR112020026629A2 (https=) |
| CO (1) | CO2021000223A2 (https=) |
| EA (1) | EA202092893A1 (https=) |
| IL (1) | IL279760B2 (https=) |
| MX (1) | MX2020013831A (https=) |
| WO (1) | WO2020002353A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025204688A1 (ja) * | 2024-03-26 | 2025-10-02 | 株式会社ダイセル | リン脂質膜保護用液体組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
| EP0208764A4 (en) | 1985-01-11 | 1987-10-08 | Univ California | METHOD FOR PRESERVING LIPOSOMES. |
| US4963362A (en) | 1987-08-07 | 1990-10-16 | Regents Of The University Of Minnesota | Freeze-dried liposome mixture containing cyclosporin |
| DE69211691T2 (de) | 1991-04-19 | 1997-01-16 | Nexstar Pharmaceuticals Inc., Boulder, Col. | Pharmazeutische formulierung und pharmazeutisches verfahren |
| WO1996040064A1 (en) | 1995-06-07 | 1996-12-19 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications |
| TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
| US5958378A (en) * | 1996-07-03 | 1999-09-28 | Research Development Foundation | High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
| IT1289938B1 (it) * | 1997-02-20 | 1998-10-19 | Angelini Ricerche Spa | Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e |
| AU2003237863A1 (en) | 2002-05-20 | 2003-12-12 | Research Development Foundation | Aerosol drug inhibition of lung metastases |
| EP1687635A2 (en) * | 2003-11-26 | 2006-08-09 | Applera Corporation | Ligand-containing micelles and uses thereof |
| EP1750671B1 (en) * | 2004-06-03 | 2008-10-15 | Bracco Research S.A. | Liposomal assembly for therapeutic and/or diagnostic use |
| DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
| CA2631243A1 (en) * | 2005-12-08 | 2007-06-14 | Wyeth | Liposomal compositions |
| EP1797895A1 (en) * | 2005-12-16 | 2007-06-20 | Pevion Biotech Ltd. | An adjuvant system comprising virosomes and liposomes |
| US20110070294A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Administration of Drugs Using Liposomes |
| US20140127288A1 (en) * | 2011-05-17 | 2014-05-08 | Mitsubishi Gas Chemical Company, Inc. | Liposome containing pyrroloquinoline quinone and sugar |
| EP3069711A1 (en) * | 2015-03-16 | 2016-09-21 | PARI Pharma GmbH | Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection |
-
2019
- 2019-06-25 IL IL279760A patent/IL279760B2/en unknown
- 2019-06-25 US US17/251,223 patent/US20210244664A1/en not_active Abandoned
- 2019-06-25 EA EA202092893A patent/EA202092893A1/ru unknown
- 2019-06-25 CN CN201980043201.0A patent/CN113038930A/zh active Pending
- 2019-06-25 WO PCT/EP2019/066875 patent/WO2020002353A1/en not_active Ceased
- 2019-06-25 MX MX2020013831A patent/MX2020013831A/es unknown
- 2019-06-25 AU AU2019295027A patent/AU2019295027B2/en active Active
- 2019-06-25 JP JP2020571767A patent/JP7401471B2/ja active Active
- 2019-06-25 BR BR112020026629-9A patent/BR112020026629A2/pt unknown
- 2019-06-25 EP EP19732066.6A patent/EP3813788A1/en active Pending
-
2021
- 2021-01-14 CO CONC2021/0000223A patent/CO2021000223A2/es unknown
-
2023
- 2023-05-16 US US18/317,940 patent/US20230301914A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102060210B1 (ko) | 안용 스테로이드의 합병증을 감소시키기 위한 약학 조성물 | |
| CN107427482A (zh) | 凝血酸的多囊脂质体制剂 | |
| US20110256213A1 (en) | Phospholipid micellar and liposomal compositions and uses thereof | |
| JP3245955B2 (ja) | リポソーム | |
| WO2017097196A1 (zh) | 脂质体的制备方法 | |
| CN103622924B (zh) | 一种多西他赛脂质体及其制备方法 | |
| Chen et al. | Efficacy assessment of glycyrrhetinic acid-modified liposomes loaded with doxorubicin hydrochloride and cucurbitine B for synergistic treatment of hepatocellular carcinoma | |
| JP2021528450A5 (https=) | ||
| US20230301914A1 (en) | Pharmaceutical compositions in lyophilized form | |
| JPWO2020002353A5 (https=) | ||
| CA3104445C (en) | Pharmaceutical compositions in lyophilized form | |
| JP7726884B2 (ja) | 吸入可能な免疫抑制活性成分を含む分散液の調製のためのプロセス | |
| CN106580928A (zh) | 穿心莲内酯纳米吸入剂及其在治疗细菌性肺炎中的应用 | |
| CA3161686C (en) | Process for the preparation of dispersions comprising inhalable immunosuppressive active ingredients | |
| WO2017097197A1 (zh) | 美西替康的药物组合物 | |
| EA048772B1 (ru) | Фармацевтические композиции в лиофилизированной форме | |
| NR et al. | TARGETED DRUG DELIVERY IN GASTROESOPHAGEAL REFLUX DISEASE: THE ROLE OF MUCOADHESIVE AND LIPOSOME SYSTEMS | |
| TW201705939A (zh) | 安定性高藥物劑載之奈米載劑，其製備方法及其用途 | |
| Taylor et al. | Liposomes for drug delivery: developments and possibilities | |
| CN119792540A (zh) | 以胡萝卜苷或其类似物为膜材的脂质体、其制备方法及应用 | |
| EA046086B1 (ru) | Способ получения дисперсий, содержащих ингаляционные иммуносупрессивные активные ингредиенты | |
| JP2005047815A (ja) | 微小粒子組成物又はリポソーム製剤 | |
| HK1201723B (en) | Pharmaceutical compositions to reduce complications of ocular steroid | |
| JPWO1995024201A1 (ja) | リポソーム製剤 |